LIFEWARD LTD (LFWD) Stock Fundamental Analysis

NASDAQ:LFWD • IL0011331076

0.423 USD
-0.1 (-18.65%)
Last: Feb 20, 2026, 02:34 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

LFWD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. The financial health of LFWD is average, but there are quite some concerns on its profitability. While showing a medium growth rate, LFWD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year LFWD has reported negative net income.
  • In the past year LFWD has reported a negative cash flow from operations.
  • In the past 5 years LFWD always reported negative net income.
  • In the past 5 years LFWD always reported negative operating cash flow.
LFWD Yearly Net Income VS EBIT VS OCF VS FCFLFWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -127.62%, LFWD is doing worse than 84.86% of the companies in the same industry.
  • LFWD has a worse Return On Equity (-231.80%) than 74.05% of its industry peers.
Industry RankSector Rank
ROA -127.62%
ROE -231.8%
ROIC N/A
ROA(3y)-52.11%
ROA(5y)-43.2%
ROE(3y)-76.61%
ROE(5y)-60.74%
ROIC(3y)N/A
ROIC(5y)N/A
LFWD Yearly ROA, ROE, ROICLFWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

1.3 Margins

  • With a Gross Margin value of 37.49%, LFWD is not doing good in the industry: 70.27% of the companies in the same industry are doing better.
  • LFWD's Gross Margin has declined in the last couple of years.
  • LFWD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.02%
GM growth 5Y-10.56%
LFWD Yearly Profit, Operating, Gross MarginsLFWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • LFWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, LFWD has more shares outstanding
  • The number of shares outstanding for LFWD has been increased compared to 5 years ago.
  • LFWD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LFWD Yearly Shares OutstandingLFWD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
LFWD Yearly Total Debt VS Total AssetsLFWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • LFWD has an Altman-Z score of -17.27. This is a bad value and indicates that LFWD is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -17.27, LFWD is doing worse than 85.41% of the companies in the same industry.
  • LFWD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -17.27
ROIC/WACCN/A
WACC8.73%
LFWD Yearly LT Debt VS Equity VS FCFLFWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 1.92 indicates that LFWD should not have too much problems paying its short term obligations.
  • LFWD has a Current ratio of 1.92. This is in the lower half of the industry: LFWD underperforms 63.24% of its industry peers.
  • LFWD has a Quick Ratio of 1.13. This is a normal value and indicates that LFWD is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of LFWD (1.13) is worse than 72.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.13
LFWD Yearly Current Assets VS Current LiabilitesLFWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • LFWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.30%, which is quite impressive.
  • Looking at the last year, LFWD shows a decrease in Revenue. The Revenue has decreased by -2.02% in the last year.
  • The Revenue has been growing by 39.41% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)25.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)-2.02%
Revenue growth 3Y62.63%
Revenue growth 5Y39.41%
Sales Q2Q%1.09%

3.2 Future

  • Based on estimates for the next years, LFWD will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.57% on average per year.
  • The Revenue is expected to grow by 40.19% on average over the next years. This is a very strong growth
EPS Next Y52.25%
EPS Next 2Y37.09%
EPS Next 3Y25.45%
EPS Next 5Y18.57%
Revenue Next Year-2.4%
Revenue Next 2Y29.25%
Revenue Next 3Y33.2%
Revenue Next 5Y40.19%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
LFWD Yearly Revenue VS EstimatesLFWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
LFWD Yearly EPS VS EstimatesLFWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -100 -200 -300 -400

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • LFWD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LFWD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFWD Price Earnings VS Forward Price EarningsLFWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LFWD Per share dataLFWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LFWD's earnings are expected to grow with 25.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.09%
EPS Next 3Y25.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for LFWD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LIFEWARD LTD

NASDAQ:LFWD (2/20/2026, 2:34:40 PM)

0.423

-0.1 (-18.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-19
Earnings (Next)05-13
Inst Owners4.65%
Inst Owner ChangeN/A
Ins Owners2.13%
Ins Owner Change26.89%
Market Cap7.74M
Revenue(TTM)24.50M
Net Income(TTM)-29.57M
Analysts82.5
Price Target7.4 (1649.41%)
Short Float %11.02%
Short Ratio3.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.82%
Min EPS beat(2)-86.44%
Max EPS beat(2)8.8%
EPS beat(4)1
Avg EPS beat(4)-28.68%
Min EPS beat(4)-86.44%
Max EPS beat(4)8.8%
EPS beat(8)2
Avg EPS beat(8)-17.81%
EPS beat(12)3
Avg EPS beat(12)-15.18%
EPS beat(16)3
Avg EPS beat(16)-24.07%
Revenue beat(2)0
Avg Revenue beat(2)-9.96%
Min Revenue beat(2)-16.17%
Max Revenue beat(2)-3.76%
Revenue beat(4)0
Avg Revenue beat(4)-9.94%
Min Revenue beat(4)-16.17%
Max Revenue beat(4)-3.76%
Revenue beat(8)0
Avg Revenue beat(8)-10.39%
Revenue beat(12)2
Avg Revenue beat(12)-10%
Revenue beat(16)2
Avg Revenue beat(16)-18.6%
PT rev (1m)40.32%
PT rev (3m)31.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)21.74%
EPS NY rev (1m)1.28%
EPS NY rev (3m)15.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)-1.86
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.94
FCFYN/A
OCF(TTM)-0.94
OCFYN/A
SpS1.34
BVpS0.7
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -127.62%
ROE -231.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.49%
FCFM N/A
ROA(3y)-52.11%
ROA(5y)-43.2%
ROE(3y)-76.61%
ROE(5y)-60.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.02%
GM growth 5Y-10.56%
F-Score4
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.41%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.13
Altman-Z -17.27
F-Score4
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)5.59%
Cap/Depr(5y)12.01%
Cap/Sales(3y)0.35%
Cap/Sales(5y)0.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y52.25%
EPS Next 2Y37.09%
EPS Next 3Y25.45%
EPS Next 5Y18.57%
Revenue 1Y (TTM)-2.02%
Revenue growth 3Y62.63%
Revenue growth 5Y39.41%
Sales Q2Q%1.09%
Revenue Next Year-2.4%
Revenue Next 2Y29.25%
Revenue Next 3Y33.2%
Revenue Next 5Y40.19%
EBIT growth 1Y16.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.06%
OCF growth 3YN/A
OCF growth 5YN/A

LIFEWARD LTD / LFWD FAQ

Can you provide the ChartMill fundamental rating for LIFEWARD LTD?

ChartMill assigns a fundamental rating of 3 / 10 to LFWD.


Can you provide the valuation status for LIFEWARD LTD?

ChartMill assigns a valuation rating of 1 / 10 to LIFEWARD LTD (LFWD). This can be considered as Overvalued.


What is the profitability of LFWD stock?

LIFEWARD LTD (LFWD) has a profitability rating of 0 / 10.


How financially healthy is LIFEWARD LTD?

The financial health rating of LIFEWARD LTD (LFWD) is 5 / 10.


What is the expected EPS growth for LIFEWARD LTD (LFWD) stock?

The Earnings per Share (EPS) of LIFEWARD LTD (LFWD) is expected to grow by 52.25% in the next year.